GENEX PHARMACEUTICALS INC

GENEX PHARMACEUTICALS INC

OOTC:GENX
0.00
USD
+0.00
(+100.00%)
GENEX PHARMACEUTICALS INC
OTC:GENX
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Genex Pharmaceutical, Inc. is actively involved in the creation, manufacturing, and supply of Reconstituted Bone Xenograft (RBX) across the People's Republic of China. This specialized medical device is engineered to facilitate and enhance the bone regeneration process. Its composition, a precisely balanced blend of β-tricalcium phosphate and calcium sulfate hemihydrate, ensures it functions as a catalyst for osseous repair, fully absorbing and remodeling within twelve months without leaving behind foreign materials. The company provides its bone healing solutions to a network encompassing roughly 500 hospitals and various other medical equipment clients. Genex Pharmaceutical maintains its corporate headquarters in Tianjin City, within the People's Republic of China, and trades on the OTC market.